Synaptic Function and Dysfunction in Brain Diseases
Synaptic dysfunction results in cell-intrinsic molecular mechanism modifications or changes in surrounding biochemical processes. A synaptic dysfunction at an early or late stage is a common denominator of several diseases called synaptopathies. Synaptopathy is a popular term used to define the key characteristics of the psychiatric and neurodegenerative diseases. It suggests that synaptic disorders can be the major determinant of such brain diseases.
Related Conference of Synaptic Function and Dysfunction in Brain Diseases
February 04-05, 2026
30th International Conference on Neuropharmacology and Neurochemistry
Bali, Indonesia
Synaptic Function and Dysfunction in Brain Diseases Conference Speakers
Recommended Sessions
- Brain Pathology and Oncology Research
- Brain Stimulation and Imaging
- Human Brain Mapping
- Neuropharmacology and genetic aspects of CNS function
- Neuropharmacology and Neurochemistry
- Neurotherapeutics and Case Studies
- Synaptic Function and Dysfunction in Brain Diseases
- Synaptic plasticity and memory
- Alzheimer’s and Parkinson’s Diseases
- Brain Injury and Behavioral Neuroscience
- Brain Structure and Function
- Clinical Neurophysiology and Stroke
- CNS and Brain Disorders
- Cognitive Neuroscience and Psychology
- Molecular and cellular neurochemistry
- Neurobiology and Behaviors
- Neurogenesis
- Neuroimmunology and Neurological Infections
- Neuroinformatics and Computational Neuroscience
- Neurological Disorders and Stroke
- Neurorehabilitation and Neural Repair
- Neuroscience and Artificial Intelligence
- Pre- and post-synaptic function
- Stem Cells Role in Neuro-Biological Treatment
- Synapse formation and neurotransmitter receptors
Related Journals
Are you interested in
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2026 (Indonesia)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2026 (Indonesia)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2026 (Indonesia)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2026 (Indonesia)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2026 (Indonesia)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2026 (Indonesia)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2026 (Indonesia)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2026 (Indonesia)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2026 (Indonesia)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2026 (Indonesia)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2026 (Indonesia)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)

